What does the Mankind Pharma Limited (MANKIND) stock page cover?

Mankind Pharma Limited on Anvest includes delayed price context, valuation ratios, technical indicators, shareholding trends, filing links, and peer comparison in one research workflow.

What are the current headline metrics for MANKIND?

Mankind Pharma Limited is currently shown with a delayed price near ₹2,425, P/E 53.42, and ROE N/A% in the current Anvest research snapshot.

Does the MANKIND page provide investment advice?

No. The MANKIND page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Stocks MANKINDNSEHealthcare

AI Alert

Mankind Pharma Limited

₹2,425

₹0

As of Tue, 11 Aug, 05:30 am IST

(0.00% 1Y)

52W: ——

Anvest Score

52/100

Mixed

ValuationWatch

QualityMixed

GrowthStrong

HealthHealthy

MomentumHealthy

360° AI Research Synthesis

Quality score, valuation vs peers, growth, debt risk, and momentum for MANKIND — one grounded briefing.

or open Research Studio

Mankind Pharma Limited

360° AI Research Synthesis

Research at a glance